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Modeling non-linear kinetics of hyperpolarized
[1-13C] pyruvate in the crystalloid-perfused rat
heart
E. Mariottia, M. R. Ortonb, O. Eerbeekc, J. F. Ashrufd, C. J. Zuurbierd,
R. Southwortha,e and T. R. Eykyna,b,e*
Hyperpolarized 13C MR measurements have the potential to display non-linear kinetics. We have developed an ap-
proach to describe possible non-first-order kinetics of hyperpolarized [1-13C] pyruvate employing a system of differ-
ential equations that agrees with the principle of conservation of mass of the hyperpolarized signal. Simultaneous
fitting to a second-order model for conversion of [1-13C] pyruvate to bicarbonate, lactate and alanine was well de-
scribed in the isolated rat heart perfused with Krebs buffer containing glucose as sole energy substrate, or glucose
supplemented with pyruvate. Second-order modeling yielded significantly improved fits of pyruvate–bicarbonate
kinetics compared with the more traditionally used first-order model and suggested time-dependent decreases in
pyruvate–bicarbonate flux. Second-order modeling gave time-dependent changes in forward and reverse reaction
kinetics of pyruvate–lactate exchange and pyruvate–alanine exchange in both groups of hearts during the infusion
of pyruvate; however, the fits were not significantly improved with respect to a traditional first-order model. The
mechanism giving rise to second-order pyruvate dehydrogenase (PDH) kinetics was explored experimentally using
surface fluorescence measurements of nicotinamide adenine dinucleotide reduced form (NADH) performed under
the same conditions, demonstrating a significant increase of NADH during pyruvate infusion. This suggests a simul-
taneous depletion of available mitochondrial NAD+ (the cofactor for PDH), consistent with the non-linear nature of
the kinetics. NADH levels returned to baseline following cessation of the pyruvate infusion, suggesting this to be a
transient effect. © 2016 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd.
Keywords: hyperpolarized 13C; dynamic nuclear polarization (DNP); cardiac metabolism; Langendorff perfused heart
INTRODUCTION
The heart is a highly metabolically active and energy demanding
organ that is able to utilize a variety of energy substrates,
dependent upon their relative abundance, prevailing hormonal
conditions, workload and oxygen availability (1). A number of
experimental methods are available for investigating cardiac
metabolism, including the use of radioactive tracer approaches
(2,3) and steady-state incorporation of 13C labeled metabolites
(4,5). It has recently been shown to be possible to probe cardiac
metabolism in real time (both in vivo and ex. vivo in Langendorff
preparations), by injecting hyperpolarized [1-13C] pyruvate and
observing its conversion to bicarbonate, lactate and alanine by
NMR or MRSI (6–9). Fitting of the hyperpolarized 13C MRS time
series of pyruvate and its metabolites to mathematical models
(10,11) gives estimates of rate constants for their interconver-
sion. The rate constants are dependent on a range of factors,
including substrate (12) and cofactor supply (13), membrane
transport into or out of the cell (14,15), enzyme expression levels
and enzyme activities (16). A previous study has shown that
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under conditions approximating the fed state in the perfused
heart infusion of 3mM pyruvate contributed 80% of the resulting
acetyl coenzyme A (CoA), while under fasting conditions 6mM
pyruvate contributed only 33% of the acetyl CoA, as measured
with steady-state incorporation of 13C labeled substrates,
and concluded that studies of cardiac metabolism using
hyperpolarized [1-13C] pyruvate are highly sensitive to substrate
competition (17).
The mathematical models employed to date typically use
systems of modified Bloch equations (18) to fit the MR visible
signals to first-order kinetics. These models do not make allow-
ances for any variation in rate constants during an experiment,
such as substrate or product inhibition, changes in cofactor
concentration, shifts in enzyme equilibria or perturbation of
enzyme kinetics during substrate infusion. This is potentially
problematic, because, despite the enhancements in sensitivity
that this approach affords, it still requires infusion of
hyperpolarized substrates at supra-physiological concentra-
tions. It has previously been shown that infusion of pyruvate
in the perfused heart leads to an increase in nicotinamide ade-
nine dinucleotide reduced form (NADH) (19,20), and in the case
of lactate dehydrogenase (LDH) it has been widely reported
that this enzyme is susceptible to substrate inhibition at high
pyruvate concentration (21,22). The impact of the use of these
non-physiological concentrations upon the measured rate
constants using first-order models has previously been studied
for hyperpolarized pyruvate in vivo in the heart, and showed a
linear dependence against pyruvate dehydrogenase (PDH)
activity measured by enzyme assay (10). However, the question
of whether any transient time-dependent effects are observed
in the heart during substrate infusion has not been addressed.
In this work, we describe a non-linear modeling approach
to describe the kinetics of hyperpolarized [1-13C] pyruvate
conversion to lactate, bicarbonate and alanine in the perfused
rat heart, which allows us to address this issue. The proposed
model agrees with the principle of conservation of mass,
where the hyperpolarized magnetization of the input function,
representing the pyruvate bolus, and each metabolite decays
to a non-hyperpolarized or ‘MR invisible’ pool of the same
metabolite (23). The total pool size of a given metabolite is there-
fore constant and proportional to concentration, enabling inclu-
sion of apparent enzyme cofactor concentrations in the model.
This formulation allows the modeling of possible non-linear
time-dependent kinetics during the infusion of pyruvate, and
can potentially be extended to other hyperpolarized substrates.
We studied two groups of hearts, one perfused with a stan-
dard Krebs–Henseleit buffer (KHB), where glucose was the
only source of carbohydrate, and a second group perfused
with KHB containing glucose supplemented with pyruvate.
Non-linear modeling suggests that infusion of the supra-
physiological concentrations of pyruvate necessary to perform
the 13C dynamic nuclear polarization (DNP) NMR experiment
perturbed the enzyme equilibria for LDH and alanine transam-
inase (ALT), and the steady-state flux through PDH in the
perfused heart, although in the case of LDH and ALT we were
not able to distinguish between first- and second-order
models. In further experiments using fluorescence measure-
ments from the surface of the heart, we demonstrate that
these non-linear variations in flux can be explained, in part,
by exhaustion of mitochondrial nicotinamide adenine dinucle-
otide (NAD+) by the supra-physiological concentrations of
pyruvate employed.
MATERIALS AND METHODS
Modeling higher-order kinetics of hyperpolarized substrates
The simplest model of differential equations that describes
first-order one-way kinetics of a simple reaction of
hyperpolarized substrate A*→ B* can be written.
dA tð Þ=dt ¼ kABA tð Þ  r1AA tð Þ [1]
dB tð Þ=dt ¼ kABA tð Þ  r1BB tð Þ [2]
where * denotes hyperpolarized substrate pools, kAB denotes
the first-order rate constant, r1A and r1B represent the effective
longitudinal relaxation rates of A* and B* given by r1A = 1/
T1A TR1 ln (cosθ) and r1B = 1/T1B TR1 ln (cosθ), taking into
account the loss of signal due to T1 and the application of the
RF excitation pulse characterized by a flip angle θ and repetition
time TR (24).
The model can be extended so that the hyperpolarized pool of
substrates A* and B* relax to an ‘MR invisible’ non-hyperpolarized
pool of reactants A and B (23):
dA tð Þ=dt ¼ kABA tð Þ þ r1AA tð Þ [3]
dB tð Þ=dt ¼ kABA tð Þ þ r1BB tð Þ: [4]
The above system of Equations [[1]]–[[4]] agrees with the prin-
ciple of conservation of mass, since the rate of change d[A* +A
+B* + B]/dt is zero.
This system of differential equations can be readily extended
to account for higher order reaction kinetics. For example, con-
sider a second-order reaction A* + Co.→ B*, where Co. repre-
sents a common reaction cofactor that is non-hyperpolarized,
to give a system of differential equations:
dA tð Þ=dt ¼ kABA tð ÞCo tð Þ  r1AA tð Þ [5]
dB tð Þ=dt ¼ kABA tð ÞCo tð Þ  r1BB tð Þ [6]
dA tð Þ=dt ¼ kABA tð ÞCo tð Þ þ r1AA tð Þ [7]
dB tð Þ=dt ¼ kABA tð ÞCo tð Þ þ r1BB tð Þ [8]
dCo tð Þ=dt ¼ kABðA tð Þ þ A tð ÞÞCo tð Þ [9]
This can be reduced to pseudo-first-order kinetics by introduc-
ing a time-dependent rate constant:
dA tð Þ=dt ¼ k ’AB tð ÞA tð Þ  r1AA tð Þ (10)
etc.
where k’AB tð Þ ¼ kABCo tð Þ.
Employing the above formalism, a system of differential
equations can be written for reactions of hyperpolarized
pyruvate in the heart, shown schematically in Figure 1, including
the exchange reaction of pyruvate–lactate, mediated by LDH,
the exchange reaction of pyruvate–alanine, mediated by ALT,
and the one way flux of pyruvate–CO2, mediated by PDH and
subsequent carbonic anhydrase (and pH)-mediated
interconversion of CO2 to bicarbonate, which we model as a
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single flux from pyruvate–bicarbonate, as follows.
dP tð Þ=dt ¼ k’PL tð ÞP tð Þ þ k’LP tð ÞL tð Þ  k’PA tð ÞP tð Þ
þk’AP tð ÞA tð Þk’PB tð ÞP tð Þr1PP tð ÞþU tð Þ [11]
dL tð Þ=dt ¼ k’PL tð ÞP tð Þ  k’LP tð ÞL tð Þ  r1LL tð Þ [12]
dA tð Þ=dt ¼ k’PA tð ÞP tð Þ  k’AP tð ÞA tð Þ  r1AA tð Þ [13]
dB tð Þ=dt ¼ k’PB tð ÞP tð Þ  r1BB tð Þ [14]
dP tð Þ=dt ¼ k’PL tð ÞP tð Þ þ k’LP tð ÞL tð Þ  k’PA tð ÞP tð Þ
þk’AP tð ÞA tð Þ  k’PB tð ÞP tð Þ þ r1PP tð Þ þ U tð Þ [15]
dL tð Þ=dt ¼ k’PL tð ÞP tð Þ  k’LP tð ÞL tð Þ þ r1LL tð Þ [16]
dA tð Þ=dt ¼ k’PA tð ÞP tð Þ  k’AP tð ÞA tð Þ þ r1AA tð Þ [17]
dB tð Þ=dt ¼ k’PB tð ÞP tð Þ þ r1BB tð Þ [18]
dNADc tð Þ=dt ¼ k’PL tð ÞP tð Þ þ k’PL tð ÞP tð Þ  k’LP tð ÞL tð Þ
 k’LP tð ÞL tð Þ [19]
dNADHc tð Þ=dt ¼ k’PL tð ÞP tð Þ  k’PL tð ÞP tð Þ þ k’LP tð ÞL tð Þ
þ k’LP tð ÞL tð Þ [20]
dGlu tð Þ=dt ¼ k’PA tð ÞP tð Þ  k’PA tð ÞP tð Þ þ k’AP tð ÞA tð Þ
þk’AP tð ÞA tð Þ
[21]
d αKG tð Þ=dt ¼ k’PA tð ÞP tð Þ þ k’PA tð ÞP tð Þ  k’AP tð ÞA tð Þ
k’AP tð ÞA tð Þ
[22]
dNADm tð Þ=dt ¼ k’PB tð ÞP tð Þ  k’PB tð ÞP tð Þ [23]
dNADHm tð Þ=dt ¼ k’PB tð ÞP tð Þ þ k’PB tð ÞP tð Þ [24]
Hyperpolarized substrate pools are given by an * and all
other substrates and cofactors are non-hyperpolarized. The
pyruvate pool is given by P*(t) + P(t) with an effective longitudi-
nal relaxation rate r1P, alanine is given by A*(t) + A(t) with an ef-
fective longitudinal relaxation rate r1A, lactate is given by L*(t)
+ L(t) with an effective longitudinal relaxation rate r1L and bicar-
bonate is given by B*(t) + B(t) with an effective longitudinal re-
laxation rate r1B. In the model the pseudo rate constants for
forward and reverse reactions were defined as a product of a
second-order rate constant and a time-dependent concentra-
tion term, kPL′(t) = kPLNADHc(t), kLP′(t) = kPLNADc(t), kPA′(t)
= kPAGlu(t), kAP′(t) = kPAαKG(t), kPB′(t) = kPBNADHm(t), allowing
the pseudo time-dependent rate constants to be different in
forward and reverse reactions. Cytosolic NAD+ and NADH are
given by NADc(t) and NADHc(t) respectively, glutamate is given
by Glu(t), α-ketoglutarate is given by α-KG(t) and mitochondrial
NAD+ and NADH are given by NADm(t) and NADHm(t), respec-
tively. It should be noted however that the concentrations
defined using this phenomenological approach do not corre-
spond to free cofactor concentrations, since we have not
included a full description of the enzyme–cofactor binding
kinetics (15).
Fitting to a first-order model was carried out by removing the
cofactor terms from Equations [[11]]–[[27]] and substituting the
pseudo rate constants kPL′(t) etc. for time-independent first-order
rate constants kPL, kLP etc.
The injection bolus was modeled as a gamma variate function
U*(t) that decays to a non-hyperpolarized input function U(t)
given by.
U tð Þ ¼ kin t  tarrivalð Þδeβ ttarrivalð Þ [25]
U tð Þ ¼ kin∫
t
0
β t  tarrivalð Þδeβ ttarrivalð Þdt [26]
dU tð Þ=dt ¼ βU tð Þ [27]
where tarrival is the time point at which the hyperpolarized sig-
nal of pyruvate is first detected, δ and β describe the rise and fall
of the input function and kin is the amplitude.
Langendorff heart perfusion
Hearts from male Wistar rats (220–250 g, n=5/group) were
excised and retrograde perfused in Langendorff mode with a
modified Krebs buffer (25) containing 118mM NaCl, 25mM
NaHCO3, 1.2mM MgSO4, 5.9mM KCl, 0.6mM Na2EDTA,
11.1mM glucose and 2.5mM CaCl2, pH 7.4, equilibrated with a
95% O2, 5% CO2 gas mixture at 37 °C. Coronary flow at the heart
was maintained at a constant 14ml/min to achieve a physiolog-
ical perfusion pressure of approximately 76mm Hg, monitored
by an in-line pressure transducer. The perfused heart was placed
in a glass tube in the isocentre of a 23Na–13C saddle coil (15mm)
and inserted into the vertical bore of a Bruker 9.4 T AVANCE III
spectrometer. The temperature within the scanner was main-
tained at 37 °C by warming the imaging gradients and
*
Figure 1. Schematic of the metabolic model describing the conversion
of hyperpolarized and unpolarized pyruvate (P* + P) to lactate (L* and L),
alanine (A* and A) and bicarbonate (B* and B). The rate constants kPL, kPA
are assumed the same for forward and reverse reactions whereas the
pools of cofactors NAD+c (t), NADHc(t), Glu(t), α-KG(t), NAD
+
m(t) and
NADHm(t) are freely varying in the model.
MODELLING NON-LINEAR KINETICS OF HYPERPOLARIZED PYRUVATE
NMR Biomed. (2016) © 2016 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd. wileyonlinelibrary.com/journal/nbm
calibrating the temperature at the position of the heart using an
ethylene glycol capillary. After a stabilization period of 10min,
hearts were either maintained on the control buffer described
above (the glucose only group), or switched to a second buffer
supplemented with 2.5mM pyruvate for the remainder of the
experiment (the pyruvate supplemented group).
Hyperpolarized 13C NMR spectroscopy
Pyruvic acid containing 15mM trityl radical and 1mM gadolinium
(Dotarem) was hyperpolarized in a HyperSense® (Oxford Instru-
ments) DNP at 3.35 T and 1.4 K for about 1 h. The protocol typi-
cally resulted in a 20 000-fold enhancement (corresponding to a
polarization P=16%) in the 13C MR signal from [1-13C] pyruvate.
Dissolution of the hyperpolarized pyruvate was carried out in
4ml of glucose free Krebs buffer containing NaOH and EDTA to
achieve a final solution of 50mM hyperpolarized pyruvate at
pH= 7. The hyperpolarized solution was injected into the arterial
perfusion line via a side-arm below the bore of the NMR magnet
at a constant flow (1ml/min) using an automated injector. The
final concentration of hyperpolarized pyruvate arriving at the
heart was 3.3mM. Serial 13C-MRS spectra were acquired with a
time interval of 2 s using a small flip angle pulse (θ =10°). Spectra
were baseline corrected and metabolite peaks of lactate, alanine,
bicarbonate and pyruvate were integrated.
Data analysis
All hyperpolarized time series were first normalized to the maxi-
mum pyruvate peak area obtained in each experiment. The
hyperpolarized signals P*i, L*i, A*i and B*i measured at times t1,
t2, …, tN were then fit simultaneously to the differential equa-
tions [[10]]–[[26]], using the ordinary differential equation solver
in MATLAB (MathWorks®) assuming zero signal at t< tarrival for
all hyperpolarized and non-polarized substrates. All variables
kPL, kPA, kPB, r1L, r1A, r1B, r1P, kin, tarrival, δ and β, as well as initial co-
factor concentrations NADc(0), NADHc(0), Glu(0), α-KG(0), NADm
(0) and NADHm(0), were allowed to vary freely within given
boundary conditions. The noise variance was different for the
four measured signals, so a cost function derived from a maxi-
mum likelihood analysis was used for data fitting. Gaussian noise
was assumed with separate variances on each signal. The log-
likelihood function was then maximized with respect to each
variance, leading to the following cost function (to be mini-
mized):
cost ¼ log

∑
N
i¼1
P tið Þ  P ið Þ2Þ þ log

∑
N
i¼1
L tið Þ  L ið Þ2Þ
þlog ∑N
i¼1
A tið Þ  A ið Þ2Þ þ log ∑
N
i¼1
B tið Þ  B ið Þ2Þ
 [28]
where P*(ti) etc. are the signal values predicted from the
model.
Where appropriate, statistics were performed using Student’s t
test, and P< 0.05 was taken to be significant.
NADH surface fluorescence
NADH surface fluorescence experiments were performed in two
further groups of rat hearts (n= 4 per group) perfused under
identical conditions to the hyperpolarized experiments, varying
only in that the infused pyruvate solution lacked the trityl free
radical. End-diastolic pressure was set at 4–8mm Hg using a wa-
ter filled polyethylene balloon inserted into the left ventricular
cavity. The hearts were continuously submerged in 37 °C perfus-
ate within a custom built imaging chamber. NADH surface fluo-
rescence of the left ventricle was recorded with a video
fluorometer, as previously reported (26,27). Briefly, the fluorome-
ter consisted of a 100W mercury lamp, and a camera unit hous-
ing a dichroic mirror for a digital video recorder. The fluorometer
was positioned in front of the crystal window of the imaging
chamber that contained the submerged heart. The length of
the experimental protocol was 600 s: following 60 s of baseline
perfusion, pyruvate was infused for 180 s, followed by a 180 s re-
covery period and then 180 s of total no-flow ischemia. NADH
images were recorded in the periods 0–30 s (baseline), 60–240 s
(during pyruvate infusion), 390–420 s (recovery of baseline),
and 590–600 s (end ischemia). The fluorescence images were an-
alyzed offline with MATLAB software, where the largest area of
the left ventricle visible throughout the whole experiment was
chosen and the averaged grey level determined and corrected
for fluctuations in lamp intensities by normalization with the
fluorescence intensity of a piece of uranyl positioned next to
the submerged heart and decay corrected to account for
photo-bleaching effects. NADH fluorescence was normalized to
the maximal NADH fluorescence obtained at the end of the is-
chemic period in each experiment.
RESULTS
Figure 2 shows representative hyperpolarized 13C spectra
summed across the entire time series for (a) glucose only hearts
and (b) glucose + pyruvate supplemented hearts. All spectra
displayed metabolite peaks from the parent pyruvate, pyruvate
hydrate, lactate, alanine, bicarbonate and CO2. The
13C spectra
from hearts perfused with glucose only also exhibited two fur-
ther peaks at about 175 parts per million (ppm) and at about
172 ppm, which did not appear in spectra from hearts
supplemented with pyruvate. These peaks have been previously
attributed to the C1 and C4 carbons of aspartate (28,29).
Fits from the glucose only KHB perfused hearts and the
glucose + pyruvate supplemented hearts are shown in Figures 3
and 4, respectively, presented on the same vertical axis. Second-
order fits are shown in Figures 3, 4(a), (b), for the hyperpolarized
pyruvate P* (thick black solid line), lactate L*(t) (thick blue solid
line), alanine A*(t) (thick green solid line) and bicarbonate B*(t)
(thick red solid line). Also shown in Figures 3, 4 are the resulting
non-polarized pools P(t), L(t), A(t) and B(t) (black, blue, green and
red thin dashed lines, respectively) and first-order fits for P*(t), L*
(t), A*(t) and B*(t) (black, blue, green and red thick dashed lines,
respectively). The time-dependent pseudo rate constants de-
rived from the second-order modeling are shown in Figures 3,
4(c)–(e), where kPL′(t) and kLP′(t) are the forward and reverse reac-
tions of pyruvate to lactate (solid and dashed blue lines, respec-
tively), kPA′(t) and kAP′(t) are the forward and reverse reactions of
pyruvate to alanine (solid and dashed green lines, respectively),
and kPB′(t) is the forward reaction of pyruvate to bicarbonate
(solid red line). In both groups of hearts the second-order model
yielded a time-dependent decrease in the pseudo rate constants
for the reaction of pyruvate to bicarbonate kPB′(t) as well as for
the forward reactions of pyruvate to lactate kPL′(t) and pyruvate
to alanine kPA′(t), whilst the model exhibited a time-dependent
increase in the pseudo rate constants for the reverse reactions
E. MARIOTTI ET AL.
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of lactate to pyruvate kLP′(t) and alanine to pyruvate kAP′(t).
Figures 3, 4(f)–(h) show the rate constants (mean± standard
error of the mean (SEM), n=5 per group) pre and post pyruvate
infusion derived from the second-order model and the corre-
sponding rate constants derived from the first-order model
(Table 1). The pseudo rate constant for pyruvate to bicarbonate
conversion was significantly lower in the pyruvate supplemented
hearts, kPB′(t) = 0.0059 ± 0.0004, than in those supplied with
glucose only, kPB′(t) = 0.075 ± 0.021 (*P= 0.028, Student’s t test).
The first-order rate constants kPB deviated significantly from those
estimated from the second-order model, being underestimated
by the first-order model in the glucose only hearts and
overestimated in the pyruvate supplemented hearts, reflecting
the poor fits using the first-order model. First-order rate con-
stants kPL and kPA were similar in magnitude to the pre-injection
rate constants kPL′t) and kPA′(t).
The values of T1 for each of the metabolites derived from the
fitting were not well determined using the first-order modeling
due to the relaxation rates being strongly correlated with the
rate constants for the reverse reactions, as previously demon-
strated in the literature (30). However, for the second-order
model the relaxation times were better characterized. From our
study for the glucose only perfused hearts, the relaxation times
returned from the fits were T1L = 44.3 ± 3.7 s, T1A = 60.0 ± 7.6 s,
T1B = 50.5 ± 6.1 s, T1P = 76.7 ± 4.4 s (±SEM, n=5). For the pyruvate
supplemented hearts, the relaxation rates returned from the fits
were T1L = 40.2 ± 4.6 s, T1A = 68.0 ± 8.6 s, T1B = 73.4 ± 3.1 s,
T1P = 76.0 ± 5.0 s (±SEM, n= 5). Since our hearts are perfused with
a crystalloid buffer these relaxation times will be longer than
in vivo or in a blood perfused heart, but nonetheless are close
to values previously reported in vitro for each metabolite of
T1L = 45 s (at 3 T), T1A = 42 s (at 3 T), T1B = 50 s (at 3 T), T1P = 67 s
(at 3 T) (16).
Figure 5 shows the NADH surface fluorescence measurements
under the same conditions as the hyperpolarized experiments,
i.e. perfusion with buffer containing glucose only (a) and (c), or
glucose supplemented with 2.5mM pyruvate (b) and (d), with
an additional 3min infusion of 50mM pyruvate (denoted by
the shaded area). Representative whole heart NADH surface fluo-
rescence images are shown at time points a before pyruvate in-
fusion, b at the end of the pyruvate infusion, c post stopping the
pyruvate infusion and d during global ischemia in the two
groups. Figure 5(e), (f) shows the mean NADH fluorescence in-
tensity normalized to the total NADH fluorescence (measured
during global ischemia) at the time points a before pyruvate in-
fusion, b at the end of the pyruvate infusion and c post stopping
the pyruvate infusion in the two groups, respectively. In both
groups of hearts there was a significant increase of NADH signal
(*P< 0.05) at the end of the pyruvate infusion, time point b. In
the glucose only perfused hearts normalized NADH was 0.19
± 0.06 at baseline, increasing to 0.67 ± 0.05 at the end of the py-
ruvate infusion, returning to 0.16 ± 0.05 post stopping the infu-
sion. In the pyruvate supplemented hearts normalized NADH
was 0.76 ± 0.04 at baseline, increasing to 0.87 ± 0.01 at the end
of the pyruvate infusion, returning to 0.66 ± 0.04 post stopping
the infusion. In both groups of hearts the NADH signal post stop-
ping the infusion, time point c, recovered to and was not signif-
icantly different from the baseline NADH signal measured before
pyruvate infusion. Baseline NADH fluorescence, at time point a,
was significantly greater in the pyruvate supplemented hearts
than in those perfused with glucose alone. Left ventricular devel-
oped pressure (LVDP) and heart rate (HR) are shown in Figure 5
(g), (h) and (i), (j), respectively, shown on the same timescale as
the NADH surface fluorescence measurements. Cardiac function
was not significantly perturbed during pyruvate infusion.
DISCUSSION
We have developed a modeling approach to assess possible
non-linear kinetics of hyperpolarized pyruvate in the crystalloid
perfused rat heart. A second-order model yielded good agree-
ment with the hyperpolarized 13C experimental data in two
groups of hearts perfused with either glucose only buffer or glu-
cose buffer supplemented with pyruvate. We were simulta-
neously able to fit pyruvate, lactate, alanine and bicarbonate
dynamics, suggesting non-linear kinetics during the infusion of
hyperpolarized pyruvate. In the case of the pyruvate to bicarbon-
ate kinetics the data was poorly fit by a first-order model in the
glucose only perfused hearts (R2 = 0.539 ± 0.283), which was sig-
nificantly improved in the second-order model (R2 = 0.978
± 0.008). Second-order fitting also led to an improvement in
the bicarbonate fitting of the pyruvate supplemented hearts
(R2 = 0.931 ± 0.022) compared with first-order fitting (R2 = 0.925
± 0.048) but was not significant. Pyruvate to lactate fits were im-
proved in the glucose only perfused hearts (R2 = 0.957 ± 0.033)
with respect to the first-order model (R2 = 0.950 ± 0.030) and also
improved by second-order modeling in the pyruvate supple-
mented hearts (R2 = 0.968 ± 0.011) with respect to first-order
modeling (R2 = 0.960 ± 0.011), although in neither case was this
significant. Pyruvate to alanine kinetics were not improved by
second-order fitting and were indistinguishable from the first-
order fits in both groups of hearts.
In both groups of hearts the second-order model suggested
a time-dependent decrease in flux through the PDH complex
during the pyruvate infusion, which could reflect a perturba-
tion due to the change in substrate concentration during
Figure 2. A representative summed hyperpolarized 13C spectra from
isolated rat hearts perfused with Krebs buffer containing (a) 10mM glu-
cose and (b) 10mM glucose supplemented with 2.5mM pyruvate. The
spectra display peaks from the injected pyruvate, pyruvate hydrate, lac-
tate, alanine, bicarbonate and CO2. In addition the hearts in (a) also
displayed peaks from C1 and C4 aspartate which were absent in (b).
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the infusion and subsequent shift of steady-state equilibrium
kinetics, but other factors may also play a role, including
change in enzyme activity due to substrate inhibition or a
change in activity due to exhaustion of cofactor availability,
for example NAD+. It has previously been shown that infusion
of pyruvate in the perfused heart leads to an increase in
NADH (19,20), which was attributed to increased flux of
pyruvate into the TCA cycle and subsequent increased NADH
production. However, in our experiments the flux of pyruvate
to bicarbonate was significantly lower in the pyruvate supple-
mented hearts than in those supplied with glucose only. Since
the PDH reaction is uni-directional, we postulated that
pyruvate infusion leads to a depletion of mitochondrial
NAD+ (conversion to NADH) and that the flux is therefore
dependent on the availability of this cofactor, leading to a
reduction in the rate.
To investigate this further, we measured NADH surface auto-
fluorescence in parallel groups of hearts perfused under the
same conditions as for the hyperpolarized experiments. Surface
autofluorescence measurements of NADH have previously been
shown to be dominated by mitochondrial NADH (31). Our exper-
iments showed a significant time-dependent increase in NADH
during the pyruvate infusion in both groups of hearts and a
significantly elevated baseline NADH in pyruvate supplemented
hearts, consistent with previous studies (19,20). Assuming the
total pool size of mitochondrial NAD+ + NADH to be constant
within the timescale of the infusion, then the time-dependent
increase in NADH infers a concomitant time-dependent decrease
of NAD+ during pyruvate infusion as well as a reduced baseline
NAD+ in the pyruvate supplemented hearts, supporting our
hypothesis that the kinetics of hyperpolarized [1-13C] pyruvate
through PDH is non-linear and subject to the decreased availabil-
ity of mitochondrial NAD+. Cardiac function reflected by HR and
LVDP was not significantly perturbed during the infusion and
NADH surface fluorescence returned to baseline values after
stopping the infusion in both groups of hearts, suggesting this
to be a transient effect.
The second-order model suggested non-linear kinetics and
a time-dependent decrease in the derived pseudo rate con-
stants for the forward reaction of both pyruvate to lactate
and pyruvate to alanine. Conversely, the model suggested a
time-dependent increase of the pseudo rate constants for
the reverse reactions. However there was no significant differ-
ence between the goodnesses of fit (R2) for the two models,
and from the fitting alone it is not possible to distinguish be-
tween first- and second-order models from the current data.
Figure 3. (a), (b) Representative fits of the glucose only perfused hearts showing (a) the hyperpolarized pyruvate curves P* (thick solid black line) and
the resulting non-polarized pyruvate pool P (dashed line), (b) the hyperpolarized lactate L*(t), alanine A*(t) and bicarbonate B*(t) (blue, green and red
thick solid lines, respectively) with the resulting non-polarized pools L(t), A(t) and B(t) (red, green and blue dashed lines, respectively). Overlaid first-or-
der fits are also shown (thick dashed lines). (c)–(e) The pseudo rate constants kPL′(t) (solid line) and kLP′(t) (dashed line) are shown in (c), kPA′(t) (solid line)
and kAP′(t) (dashed line) in (d) and kPB′(t) (solid line) in (e). (f)–(h) Mean rate constants kPL′(t), kPA′(t) and kPB′(t), pre hyperpolarized pyruvate injection and
post pyruvate injection derived from the second-order and first-order fitting (n = 5, ±SEM).
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This suggests that cofactor concentrations may not limiting in
either case due to the reversible nature of the enzyme reac-
tions catalyzed by LDH and ALT and subsequent regeneration
of these cofactors in either forward or reverse reactions.
The fits returned values of the reverse rate constants that were
greater than the forward rate constants for both k′LP and k′AP. To
investigate this further we also performed fits to one-way kinet-
ics, i.e. no backreaction, and in the case of both lactate and
alanine a one-way model also gave satisfactory fits (data not
shown). The backreaction kinetics have previously been shown
to be strongly correlated with the relaxation rates, introducing
significant errors in estimation of these parameters. The greater
Figure 4. (a), (b) Representative fits of the pyruvate supplemented perfused hearts showing (a) the hyperpolarized pyruvate curves P* (thick solid
black line) and the resulting non-polarized pyruvate pool P (dashed line), (b) the hyperpolarized lactate L*(t), alanine A*(t) and bicarbonate B*(t) (blue,
green and red thick solid lines, respectively) with the resulting non-polarized pools L(t), A(t) and B(t) (red, green and blue dashed lines, respectively).
Overlaid first-order fits are also shown (thick dashed lines). (c)–(e) The pseudo rate constants kPL′(t) (solid line) and kLP′(t) (dashed line) are shown in
(c), kPA′(t) (solid line) and kAP′(t) (dashed line) in (d) and kPB′(t) (solid line) in (e). (f)–(h) Mean pseudo rate constants kPL′(t), kPA′(t) and kPB′(t), pre
hyperpolarized pyruvate injection and post pyruvate injection derived from the second-order and from first-order fitting (n = 5, ±SEM).
Table 1. Kinetic parameters derived from second-order modeling employing Equations [[10]]–[[26]] and the full model described
in Figure 1 as well as corresponding kinetic parameters derived from a first-order model
Glucose only R2 (n=5) Pyruvate supplemented R2 (n=5)
kPL′(Pre) 0.082 ± 0.022 0.957 ± 0.033 0.034 ± 0.011 0.968 ± 0.011
kPL′(Post) 0.049 ± 0.013 0.023 ± 0.009
kPL (first order) 0.083 ± 0.020 0.950 ± 0.030 0.041 ± 0.005 0.960 ± 0.011
kPA′(Pre) 0.005 ± 0.001 0.971 ± 0.016 0.0029 ± 0.0002 0.951 ± 0.018
kPA′(Post) 0.0017 ± 0.0005 0.0009 ± 0.0001
kPA (first order) 0.007 ± 0.0017 0.971 ± 0.026 0.003 ± 0.0006 0.949 ± 0.039
kPB′(Pre) 0.075 ± 0.021 0.978 ± 0.008 0.0059 ± 0.0004 0.931 ± 0.022
kPB′(Post) 7.9 × 1012 ± 8.7 × 1012 6.7 × 109 ± 4.0 × 109
kPB (first order) 0.016 ± 0.0003 0.539 ± 0.283 0.013 ± 0.0007 0.925 ± 0.048
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magnitude of these rate constants in the current data likely
reflects the modeling rather than underlying physiology. Mea-
surement of the reverse exchange rate constants has recently
been addressed using magnetization exchange experiments
(32); experiments employing hyperpolarized lactate (33) or
alanine (34) could also be performed.
The aspartate peaks evident in glucose only perfused hearts
were absent from pyruvate supplemented hearts. The appear-
ance of the C4 aspartate peak has been previously attributed
to scrambling of the C1 and C4 labels due interconversion with
fumarate in the TCA cycle (due to its symmetric nature). How-
ever the absence of these peaks in the pyruvate supplemented
hearts is worth noting, since the malate–aspartate shuttle is
responsible for translocating electrons from cytosolic NADH
across the inner mitochondrial membrane. Since this shuttle is
dependent upon NAD+/NADH ratio, the elevated baseline
NADH that we observe in these hearts using surface fluores-
cence would lead to a reduced requirement to translocate
electrons from glycolytically derived NADH from the cytosol
into the mitochondria, and therefore potentially reduced
activity of the malate–aspartate shuttle in the pyruvate supple-
mented hearts.
To date much work has been carried out to explore the utility
of hyperpolarized substrates as a measure of metabolic fluxes or
exchange rates of a number of enzymes and transporters in
biological systems including the heart, cancer, the liver and the
brain, in ex. vivo perfused models such as that presented here
as well as in vitro cell systems or in vivo disease models.
Successes have been attributed to the ability to measure
changes in kinetics either in response to disease progression or
employing the method as a potential biomarker of treatment
response (35). Results have typically been interpreted as a mea-
sure of fluxes or exchange using first order models. Our kinetic
data obtained from the perfused heart suggests that the as-
sumption that these measurements display first-order kinetics
may not always hold, particularly for PDH in a highly metaboli-
cally active and flexible organ such as the perfused heart. In
our experiments we infused a solution of 50mM hyperpolarized
pyruvate, which resulted in 3.3mM hyperpolarized pyruvate ar-
riving at the myocardium after dilution in two groups of hearts,
perfused with glucose only buffer in the absence of pyruvate
or supplemented with 2.5mM pyruvate. These concentrations
greatly exceed the endogenous concentration of pyruvate in
the blood (typically about 0.1mM (36)) and therefore resulted
in a metabolic perturbation in our experiments due to a change
in substrate supply during infusion, accounting for the non-linear
response. Employing second-order models may yield novel
insights, particularly with respect to the importance of enzyme
cofactor pools in the measured kinetics.
We conclude that infusion of supra-physiological concentra-
tions of pyruvate into the glucose only and glucose + pyruvate
supplemented perfused hearts leads to a transient perturbation
of the steady-state kinetics of PDH that leads to non-linear
dynamics and non-first-order kinetics, likely related to exhaus-
tion of NAD+ as a cofactor. For lactate and alanine kinetics we
were not able to distinguish between first- and second-order
models and it was not conclusive from the current data whether
the infusion also led to a perturbation of the enzyme equilibria of
these reactions. These are potentially important considerations
when utilizing and interpreting NMR data obtained following
Figure 5. (a), (b) Representative NADH surface fluorescence images from (a) glucose only perfused heart and (b) glucose + pyruvate supplemented
heart at time points a corresponding to the baseline pre pyruvate infusion, b at the end of the pyruvate infusion, c post stopping the infusion and
d during global stopped flow ischemia. (c), (d) NADH surface fluorescence intensity from the left ventricle normalized to the total during ischemia in
glucose only perfused hearts and in pyruvate supplemented perfused hearts, respectively. (e), (f) Mean NADH fluorescence intensity normalized to
the total NADH fluorescence (measured during global ischemia) at the time points a before pyruvate infusion, b at the end of the pyruvate infusion
and c post stopping the pyruvate infusion in the two groups, respectively (*P< 0.05, n = 4). (g), (h) and (i), (j) Functional measurements of LVDP and
HR in the two groups, respectively.
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infusion of non-physiological concentrations of hyperpolarized
substrates.
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